What is the share price of Sresta Natural Bioproducts Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Sresta Natural Bioproducts Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Sresta Natural Bioproducts?

The latest standalone P/E ratio of Sresta Natural Bioproducts as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Sresta Natural Bioproducts Ltd?

The latest standalone P/B ratio of Sresta Natural Bioproducts Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Sresta Natural Bioproducts Ltd?

The 52-week high of Sresta Natural Bioproducts Ltd is Rs. and the 52-week low is Rs. .

Sresta Natural Bioproducts Ltd Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Sresta Natural Bioproducts Ltd
Brand: Sresta Natural Bioproducts

Sresta Natural Bioproducts Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Agriculture | Small Cap | Sresta Natural Bio. Share Price

Sresta Natural Bioproducts Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Agriculture | Small Cap | Sresta Natural Bio. Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-0.7

TTM Sales

₹176 Cr.

Book Value per Share

₹47.8

P/E Ratio

0.00

Industry PE

15.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-1.42%

Return on Capital Employed (ROCE)

2.49%

Return on Assets (ROA)

-0.82%

Operating Profit Margin

8.6%

Net Profit Margin

-0.72%

Gross Profit Margin

7.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

4.23%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

70.11%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹71 Cr.

Equity

₹18.8 Cr.

Face Value

₹10

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	-27.8%	3.5%	0.9%	0.9%	0.4%	3.3%	4.1%	-7.5%	-1.9%	2.5%	-
Value Creation Index ⓘ	-3.0	-0.8	-0.9	-0.9	-1.0	-0.8	-0.7	-1.5	-1.1	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	10.1	16.1	29.7	47	79.6	111	156	169	169	176	176
Sales YoY Gr.	-	59.3%	84.3%	58.4%	69.6%	39.8%	40.6%	7.8%	0.1%	4.2%	-
Adj EPS ⓘ	-6.5	0.1	0	0.2	0.2	0.2	-0.7	-5.9	-4.2	-1.4	-0.7
YoY Gr.	-	NA	-88.9%	1500%	0%	37.5%	-418.2%	NA	NA	NA	-
BVPS (₹) ⓘ	6	21	24.4	27.9	33.4	47.4	59.4	54.9	50.9	48.8	47.8
Adj Net Profit ⓘ	-1.7	0	0	0.2	0.2	0.3	-1	-10.3	-7.3	-2.6	-1
Cash Flow from Ops. ⓘ	0	0	0	0	0	-19.5	-24.1	-7.9	10.7	0.9	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	-0.9	-1.5	-4.4	3	42.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	37.4%	17.2%	4%	4.2%
Adj EPS ⓘ	NA	-254.8%	NA	NA
BVPSⓘ	26.3%	7.9%	-6.4%	-4.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	-34.4	0.3	0	0.6	0.5	0.5	-1.3	-10.9	-7.8	-2.9	-1.4
Op. Profit Mgn % ⓘ	-22.7	1.1	0.6	0.6	0.3	5.4	6.2	-5	5.3	8.6	NAN
Net Profit Mgn % ⓘ	-16.8	0.1	0	0.4	0.3	0.3	-0.7	-6.1	-4.3	-1.5	-0.7
Debt to Equity ⓘ	1.1	0.3	0.1	0.1	0.3	0.3	0.4	0.4	0.4	0.4	-
Working Cap Days ⓘ	149	166	204	217	203	245	254	265	263	261	0
Cash Conv. Cycle ⓘ	130	144	510	845	-1,041	128	135	161	131	112	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	10.10	16.09	29.65	46.96	79.63	111.29	156.42	168.54	168.64	175.78
Operating Expenses ⓘ +	12.39	15.92	29.47	46.68	79.42	105.29	146.67	178.02	159.74	160.64
Manufacturing Costs	0.08	0.09	0	0	0	7.68	10.85	13.47	1.74	1.70
Material Costs	8.10	10.57	-3.98	-0.27	-5.84	65.68	89.95	96.24	92.08	87.56
Employee Cost	1.60	2.57	0	0	0	3.58	5.74	9.29	9.96	10.09
Other Costs ⓘ	2.61	2.68	33.46	46.95	85.26	28.35	40.14	59.02	55.96	61.29
Operating Profit ⓘ	-2.29	0.17	0.18	0.28	0.21	6	9.75	-9.48	8.90	15.14
Operating Profit Margin (%)	-22.7%	1.1%	0.6%	0.6%	0.3%	5.4%	6.2%	-5.6%	5.3%	8.6%
Other Income ⓘ +	0.30	0.38	0	0	0	2.33	3.24	1.20	1.54	2.72
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.24	0.34	0	0	0	1.68	3.47	4.85	5.26	4.67
Depreciation ⓘ	0.14	0.16	0	0	0	5.86	8.62	1.38	12.89	14.73
Profit Before Tax ⓘ	-2.38	0.06	0.18	0.28	0.21	0.78	0.89	-14.51	-7.71	-1.55
Tax ⓘ	-0.68	0.03	0.17	0.09	0	0.29	1.45	-3.65	-0.71	-0.29
Profit After Tax	-1.70	0.02	0.01	0.19	0.21	0.49	-0.55	-10.87	-7	-1.26
PAT Margin (%)	-16.8%	0.1%	0.0%	0.4%	0.3%	0.4%	-0.4%	-6.5%	-4.2%	-0.7%
Adjusted EPS (₹)	-6.5	0.1	0.0	0.2	0.2	0.3	-0.4	-6.2	-4.0	-0.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Sresta Natural Bio. - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	4.25	11.27	26.37	34.60	45.23	71.33	91.25	97.17	90.25	89.06
Share Capital ⓘ	5.30	7.67	10.83	13.32	14.71	17.53	19.29	18.78	18.81	18.25
Reserves ⓘ	-1.05	3.60	15.54	21.28	30.52	53.80	71.96	78.39	71.45	70.81
Debt +	4.51	2.78	1.58	2.50	14.39	17.47	35.45	29.49	25.86	31.53
Long Term Debt	4.51	2.78	0	0	0	3	5.54	5.02	4.90	2.34
Short Term Debt	0	0	1.58	2.50	14.39	14.48	29.91	24.46	20.95	29.19
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.18	0.88	1.61	3.97	5.95	19.65	15.83	14.84	27.15	28.68
Others Liabilities ⓘ	-2.43	-2.38	-0.54	-0.24	0.43	2.13	7.79	7.21	7.50	8.61
Total Liabilities ⓘ	6.51	12.55	29.01	40.82	66	110.58	150.32	148.71	150.76	157.88
Fixed Assets
Net Fixed Assets ⓘ +	1.17	1.20	2.49	3.89	3.90	8.94	17.27	17.82	17.30	16.39
Gross Block	1.54	1.72	3.21	4.89	5.23	10.89	20.20	22.13	23	23.04
Accumulated Depreciation	0.36	0.52	0.72	1	1.33	1.95	2.93	4.31	5.71	6.66
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0.59	0.59	3.02	3.72	6.03	5.49	5.49	5.49	5.20	5.20
Inventories	2.12	4.23	9.28	13.16	18.69	38.96	48.15	41.38	33.88	43.40
Trade Receivables	2.34	5.10	6.56	10.18	21.14	24.52	43.75	46.78	52.41	48.80
Cash Equivalents	0.10	0.03	0.37	0.55	0.28	2.41	3.29	4.90	5.86	7.18
Others Assets ⓘ	0.19	1.39	7.29	9.32	15.96	30.26	32.38	32.33	36.11	36.92
Total Assets ⓘ	6.51	12.55	29.01	40.82	66	110.58	150.32	148.71	150.76	157.88

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	-19.48	-24.13	-7.91	10.70	0.91
PBT ⓘ	0.78	0.89	-14.51	-7.71	-1.55
Adjustment ⓘ	-1.03	-0.66	12.41	4.10	7.58
Changes in Working Capital ⓘ	-19.24	-24.37	5.19	13.6	-5.26
Tax Paid ⓘ	0	0	3.56	0.71	0.14
Cash Flow From Investing Activity ⓘ +	-5.66	-8.52	-2.47	-0.88	-0.61
Capex	-5.66	-9.33	-1.95	-0.88	-0.61
Net Investments	0	0	0	0	0
Others ⓘ	0	0.81	-0.51	0	0
Cash Flow From Financing Activity ⓘ +	27.44	33.53	11.99	-8.86	1.02
Net Proceeds from Shares ⓘ	25.15	1.76	0.11	0.03	0.02
Net Proceeds from Borrowing ⓘ	0	0	0	0	0
Interest Paid ⓘ	-1.57	-3.26	-4.52	-5.01	-4.40
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	3.86	35.03	16.40	-3.88	5.40
Net Cash Flow ⓘ	2.30	0.88	1.61	0.96	1.32

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	-76.62	0.63	0.04	0.65	0.54	0.88	-0.72	-11.92	-7.58	-1.42
ROCE (%)	-27.76	3.52	0.87	0.86	0.43	3.32	4.05	-7.46	-1.92	2.49
Asset Turnover Ratio	1.73	1.69	1.43	1.34	1.49	1.26	1.2	1.13	1.13	1.14
PAT to CFO Conversion(x)	N/A	0	0	-102.53	-114.9	-16.14	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	50.30	84.40	71.80	65.10	71.80	74.90	79.70	98	107.40	105.10
Inventory Days	92.30	72.10	83.20	87.20	73	94.50	101.60	96.90	81.50	80.20
Payable Days	18	18.30	-114	-3,820.70	-310	71.10	72	58.20	83.20	116.40

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sresta Natural Bioproducts Ltd FAQs

The current trading price of Sresta Natural Bio. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sresta Natural Bio. stood at ₹0.00 Cr

The latest P/E ratio of Sresta Natural Bio. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Sresta Natural Bio. as of 31-Dec-1969 is 0.00.

The 52-week high of Sresta Natural Bio. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sresta Natural Bio. is ₹176 ( Cr.) .

Data is not available for this company.

No data found

About Sresta Natural Bioproducts Ltd

No data to display

Sresta Natural Bioproducts Ltd

Sresta Natural Bioproducts Ltd

10 Year X-Ray :